UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

291.67 5.52 −1.86%
Market cap
$2.3B
P/E
31.2×
Fwd P/E
23.6×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

22.89 25.03 21.75 28.33
P/S ratio
2.57 2.84 2.46 3.25
P/FCF ratio
17.60 21.65 21.49 33.37
P/Operating CF
42.85 101.59 466.54 131.44
P/B ratio
3.81 4.04 3.41 4.44
Price to Tangible BV
24.30 19.98 14.32 15.70
EV/Sales
2.81 3.05 2.67 3.44
EV/EBITDA
15.02 16.50 14.52 18.75
EV/Operating CF
16.90 20.02 20.00 30.38
EV/FCF
19.23 23.28 23.38 35.36
Quick Ratio
1.28 1.45 1.59 1.61
Current Ratio
2.41 2.69 2.91 3.00
Net Debt/EBITDA
5.04 4.89 4.64 3.71
Debt/Assets
24.59% 22.81% 22.39% 19.30%
Debt/Equity
0.40 0.35 0.34 0.28
Asset Turnover
0.93 0.94 0.92 0.96
Operating CF/Net income
2.19 0.96 0.18 0.75
Capex/Depreciation
(0.69) (0.78) (0.34) (0.23)
Interest Coverage
9.77 11.14 13.45 16.42
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.34% 14.08% 13.63% 13.08%
Intangible Assets out of Total Assets
0.52 0.52 0.50 0.49
Share Based Compensation of Revenue
1.27% 1.61% 1.77% 1.85%
Graham Net Nets
(0.03) (0.02) (0.01) 0.01
Graham Number
101.37 104.78 106.69 112.17
Earnings Yield
4.37% 3.99% 4.60% 3.53%
Free Cash Flow Yield
5.68% 4.62% 4.65% 3.00%
Revenue per Share
20.04 19.33 19.97 22.48
Operating CF per Share
4.66 2.19 0.42 2.02
Capex per Share
(0.44) (0.50) (0.22) (0.15)
Free Cash Flow per Share
4.22 1.69 0.20 1.87
Cash per Share
2.36 2.63 2.59 1.17
Shareholders Equity per Share
52.37 55.01 56.84 59.74
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
52.37 55.01 56.84 59.74
Free Cash Flow
32.55 12.98 1.52 14.46
Working Capital
115.75 126.14 147.09 156.59
Capital Expenditures
(3.38) (3.86) (1.69) (1.15)
Net Current Asset Value
(50.94) (30.20) (11.70) 15.41
EV/EBIT
18.06 19.93 17.56 22.57
Capex to Sales
0.02 0.03 0.01 0.01
Price to Operating Income
16.54 18.53 16.15 21.30
Other line items
Average Receivables
89.20 88.94 99.74 102.00
Average Payables
27.86 24.28 29.07 27.81
Average Inventory
87.42 87.20 91.91 92.65
Average Assets
645.66 642.04 658.66 658.28
Average Common Equity
366.53 383.32 399.77 423.96

Fold the line items

Columns are period end dates